Interfacing Continuous Measurement of Glucose and Physical Activity to Predict Glycemic Control in Individuals with Type 2 Diabetes by Blankenship, Jennifer
University of Massachusetts Amherst 
ScholarWorks@UMass Amherst 
Doctoral Dissertations Dissertations and Theses 
March 2017 
Interfacing Continuous Measurement of Glucose and Physical 
Activity to Predict Glycemic Control in Individuals with Type 2 
Diabetes 
Jennifer Blankenship 
Follow this and additional works at: https://scholarworks.umass.edu/dissertations_2 
 Part of the Exercise Science Commons 
Recommended Citation 
Blankenship, Jennifer, "Interfacing Continuous Measurement of Glucose and Physical Activity to Predict 
Glycemic Control in Individuals with Type 2 Diabetes" (2017). Doctoral Dissertations. 865. 
https://scholarworks.umass.edu/dissertations_2/865 
This Open Access Dissertation is brought to you for free and open access by the Dissertations and Theses at 
ScholarWorks@UMass Amherst. It has been accepted for inclusion in Doctoral Dissertations by an authorized 













ABSTRACT	INTERFACING	CONTINUOUS	MEASUREMENT	OF	GLUCOSE	AND	PHYSICAL	ACTIVITY	TO	PREDICT	GLYCEMIC	CONTROL	IN	INDIVIDUALS	WITH		TYPE	2	DIABETES			FEBRUARY	2017		JENNIFER	M.	BLANKENSHIP,	B.A.,	UNIVERSITY	OF	MASSACHUSETTS	AMHERST		M.S.,	UNIVERSITY	OF	MASSACHUSETTS	AMHERST		Ph.D.,	UNIVERSITY	OF	MASSACHUSETTS	AMHERST		Directed	by:	Professor	Barry	Braun		Physical	activity	is	a	cornerstone	in	the	management	of	hyperglycemia	and	risk	of	cardiovascular	disease	in	type	2	diabetes	(T2D).	However,	the	dose	response	relationship	between	physical	activity	and	glucose	regulation	is	not	well	defined.	The	overall	goal	of	this	dissertation	was	to	assess	the	magnitude	and	timing	of	changes	of	daily	glucose	concentrations	in	response	to	continuous	and	intermittent	light	physical	activity	in	T2D.		Through	utilizing	continuous	glucose	monitors	(CGM)	and	physical	activity	monitoring	concurrently,	we	were	able	to	assess	the	glycemic	impact	of	physical	activity	and	sedentary	behavior	in	the	free-living	environment.		Study	1	aimed	to	examine	the	effect	of	regularly	interrupting	7-h	of	prolonged	sitting	(SIT)	with	brief	bouts	of	light	walking	(LW)	or	simple	resistance	activities	(SRA)	on	22-h	glucose	homeostasis	in	adults	with	T2D.	Twenty-four	individuals	with	T2D	completed	3	conditions	(SIT,	LW	and	SRA)	in	the	laboratory.	A	CGM	was	worn	during	the	laboratory	conditions	and	in	the	free-living	environment	through	next	morning.	Compared	to	SIT,	both	LW	and	SRA	reduced	mean	22-h	glucose	concentrations	(SIT: 11.5±0.3, LW: 8.7±0.3 and SRA: 8.8±0.3 mmol.L-1),	daily	
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Rynders	et	al.,	2014		 1h	pre-meal	 3h	after	exercise	recovery	 ê	3h	glucose	AUC	Oberlin	et	al.,	2014		 Pre-meal	(morning)	 0-48h	post	exercise	 ê	24h	mean	glucose	
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	 Total	time	(min)	 SIT	 LW	 SRA		Laboratory	 Wear	time		 504	±	3	 504	±	3	 502	±	3	Sitting		 499	±	3	 449	±	3*	 453	±	3*	Standing		 4	±	1	 9	±	1*	 30	±	1*†	Stepping		 2	±	1	 46	±	1*	 19	±	1*†	
	Evening	 Wear	time		 417	±	24	 418	±	25	 375	±	24	Sitting	 279	±	11	 265	±	11	 262	±	11	Standing		 108	±	21	 119	±	22	 79	±	21	Stepping		 30	±	2	 34.6	±	3	 35	±	2		Laboratory+Evening	 Wear	time		 919	±	29	 900	±	30	 839	±	30*	Sitting	 777	±	17	 700	±	18*	 682	±	17*	Standing		 110	±	21	 123	±	22	 105	±	21	Stepping		 32	±	3	 79	±	3*	 52	±	3*†	Data	are	expressed	as	mean	±	SEM.	SIT,	Uninterrupted	 sitting.	 LW,	 sitting	+	 light-intensity	walking	bouts.	SRA,	sitting	+	simple	resistance	activity	bouts.	*significantly	different	from	SIT	(p<0.05);	†significantly	different	from	LW	(p<0.05).		
Table	3.3:	Glycemic	Control	Over	22-h	and	Nocturnal	Glycemia	
	 	 SIT	 LW	 SRA	22-h	 Mean	glucose	(mmol.L-1)	 11.6	±	0.3	 8.9	±	0.3*	 8.7	±	0.3*	AUCtotal	(mmol.h.L-1)	 254.9	±	6.7	 194.7	±	6.6*	 191.5	±	6.6*	Time	in	hyperglycemia	(h)	 14.7	±	0.9		 6.3	±	0.8*	 6.3	±	0.9*	
Sleeping	 Mean	glucose	(mmol.L-1)	 10.6	±	0.4	 8.1	±	0.4*	 8.3	±	0.4*	AUCtotal	(mmol.h.L-1)	 86.9	±	3.7	 64.6	±	3.6*	 68.0	±	3.7*	Time	in	hyperglycemia	(h)	 4.7	±	0.4	 1.4	±	0.4*	 1.8	±	0.4*	Waking	glucose	(mmol.L-1)	 10.3	±	0.3		 7.6	±	0.3*	 7.7	±	0.3*	Data	 are	 expressed	 as	 mean±SEM.	 SIT,	 Uninterrupted	 sitting.	 LW,	 sitting	 +	 light-intensity	walking	bouts.	 SRA,	 sitting	+	 simple	 resistance	activity	bouts.	 Sleeping	 is	the	time-period	from	bedtime	until	end	of	the	22-h	period.	AUCtotal,	total	area	under	the	curve.	*significantly	different	from	SIT	(p<0.05).				
	56	
Table	3.4:	Glycemic	Variability	Over	22-h	
	 	 SIT	 LW	 SRA	MODEL	1	 %	CV	 19.8	±	1.2	 21.8	±	1.2	 20.7	±	1.2	SDglucose	(mmol/L)	 2.3	±	0.1	 1.9	±	0.1*	 1.8	±	0.1*	MAGE	(mmol/L)	 5.9	±	0.3	 4.6	±	0.3*	 4.3	±	0.3*		CONGA1	(mmol/L)	 2.0	±	0.1	 1.6	±	0.1*	 1.5	±	0.1*	













































































































• Resting metabolic rate
• Body composition (DEXA)
• Study food
• Physical activity monitors 
• CGM insertion
Wear CGM and physical activity 
monitors for 7 days. Perform 
instructed conditions on study days.
• Return physical activity monitors
• CGM removal




2 Study Day 1
3 Washout Day
4 Study Day 2 
5 Washout Day
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Activity Volume Groups and Mean Postprandial Glucose
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	 Carbohydrate	(%)	 Fat	(%)	 Protein	(%)	
Breakfast	 55.8	 30.0	 15.4	
Lunch	 54.7	 28.4	 16.6	
Dinner	 55.9	 29.2	 15.4		
Table	4.3:	Percent	of	Complete	Continuous	Glucose	Monitor	Data	
	 24-hour		 Breakfast	 Lunch	 Dinner	
CON	 80%	(n=24)	 77%	(n=	23)	 77%	(n=23)	 87%	(n=26)	
EX	 93%	(n=28)	 73%	(n=22)	 87%	(n=26)	 93%	(n=28)	

















	 Low	(n=11)	 Mod	(n=10)	 High	(n=9)	
Age	(yrs)	 67.9	±	5.8	 61.2	±	9.8	 62.3	±	7.7	
Weight	(kg)	 89.4	±	17.2	 95.16	±	16.2	 83.75	±	16.2	
BMI	(kg/m2)	 32.1	±	4.6	 32.9	±	5.8	 30.1	±	6.1	
Years	since	menopause	 15.3	±	10.8	 9.3	±	6.2	 14.2	±	8.1	
Years	since	diabetes	 10.7	±	6.0	 7.7	±	5.1	 12.0	±	12.0	
RMR	 1593.1	±	337.8	 1970.8	±	412.9	 1751	±	340	
TDEE	 2253.8	±	460.8		 2606.8	±	705.8	 2436.5	±	474.1	
Body	fat	(%)	 41.7	±	6.9	 37.3	±	12.2	 36.3	±	10.6	
HbA1c	(%)	 7.5	±	1.3	 6.9	±	0.5	 7.7	±	1.2	HbA1c=	Hemoglobin	A1c,	BMI=	Body	Mass	Index	
	
Table	4.6:	Total	Daily	Physical	Activity	(mean	±	SD)		
	 Control	 Exercise	 Breaks	 Normal	Activity	
Sitting	time	(min)	 591.0	±	144.8	 586.5	±	121.3	 566.8	±	114.5	 582.7	±	151.0	
Standing	time(min)	 225.4	±	130.0	 201.5	±	98.2	 230.3	±	122	 252.8	±	105.1	
Stepping	time	(min)	 85.4	±	42.6		 114.1	±	46.1*	 103.7	±	48.4*	 97.1	±	54.3	
Number	of	steps		 3157	±	1597.0	 4810	±	2125.7*	 4055	±	2431.2*	 3657	±	2317.4	
Sit	to	stand	transitions	 52.7	±	24.5		 43.8	±	12.5*	 53.8	±	18.3	 50.0	±	20.4	
Duration	of	prolonged	
sitting	(>30	min)	 316.1	±	183.2	 357.0	±	132.4		 233.7	±	129.5*	 317.0	±	182.3	
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